Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$88.02 - $127.79 $413,694 - $600,613
-4,700 Reduced 56.63%
3,600 $329,000
Q2 2021

Aug 16, 2021

SELL
$105.76 - $154.96 $359,584 - $526,864
-3,400 Reduced 29.06%
8,300 $1.27 Million
Q1 2021

May 17, 2021

BUY
$78.5 - $126.48 $447,450 - $720,936
5,700 Added 95.0%
11,700 $1.23 Million
Q4 2020

Feb 16, 2021

SELL
$55.93 - $82.78 $44,744 - $66,224
-800 Reduced 11.76%
6,000 $475,000
Q1 2020

May 15, 2020

SELL
$25.01 - $42.4 $25,010 - $42,400
-1,000 Reduced 12.82%
6,800 $219,000
Q4 2019

Feb 14, 2020

BUY
$24.55 - $38.13 $191,490 - $297,414
7,800 New
7,800 $274,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.4B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.